immunity News and Research

RSS

Israeli research confirms BNT162b2 booster's effectiveness

Researchers explore the use of a third dose of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.

6 Apr 2022

How effective are mRNA boosters against to Delta and Omicron?

The current study discusses available data on the effectiveness of mRNA vaccination against Omicron.

6 Apr 2022

Researchers discover over 40 new genetic markers for Alzheimer’s disease

A new Nature Genetics study describes over 70 gene markers that appear to be significantly associated with AD risk using translational genomics.

6 Apr 2022

New platform for studying how the immune system responds to hepatitis C

A vaccine for hepatitis C has eluded scientists for more than 30 years, for several reasons. For one, the virus that causes the disease comes in many genetic forms, complicating the creation of a widely effective vaccine.

6 Apr 2022

Cryo-EM imaging of a key immune protein reveals previously unrecognized binding site

Imaging at near-atomic resolution of a key immune protein commonly known as STING has revealed a previously unrecognized binding site that appears to be pivotal for launching immune attacks, UT Southwestern scientists report in a new study.

6 Apr 2022

Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

A new study illustrated the association of immunoglobulins with blood characteristics in COVID-19 patients.

6 Apr 2022

SARS-CoV-2 transmission from human to free-roaming dogs during a severe COVID-19 outbreak in the Amazonian Region of Ecuador

A new study shows how free-roaming village dogs in an Ecuadorian village within the Amazon jungle have been infected with the virus, presumably by the human hosts.

6 Apr 2022

Self-assembling SARS-CoV-2 spike protein-directed nanoparticle vaccines

A new preprint study depicted the generation of self-assembling coronavirus disease 2019 (COVID-19) nanoparticle vaccines.

6 Apr 2022

Study highlights immune escape mutations in viral N-terminal domain supersite of SARS-CoV-2 spike variants

Researchers characterized SARS-CoV-2 spike (S) isolates extracted from the samples of two individuals infected with the virus in Peru (ΔN25) and Brazil (ΔN135) in January 2021.

6 Apr 2022

How comorbidities impact antibody response to COVID vaccination

Scientists from the United States have recently investigated the impact of pre-existing health conditions on the robustness and durability of immune responses induced by mRNA-based coronavirus disease 2019 (COVID-19) vaccination.

6 Apr 2022

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

Researchers evaluate the effectiveness of four COVID-19 vaccines against symptomatic infection, hospitalization, and death in convalescent individuals.

5 Apr 2022

SARS-CoV-2 Omicron breakthrough infections induce antibodies with cross-variant neutralization potential and recall memory B cells

Researchers reported breakthrough infections by SARS-CoV-2’s new variant of concern, Omicron, that elicited broadly cross-reactive neutralizing antibodies in the BNT162b2-vaccinated individuals.

5 Apr 2022

Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

A new study analyzed the recall of pre-existent cross-reactive memory B cells upon the SARS-CoV-2 Omicron breakthrough infections.

5 Apr 2022

Investigating extensive SARS-CoV-2 neutralizing immunoglobulins from COVID-19 recovered subjects

A new study discovered immunoglobulins with powerful broad-acting neutralizing capacity against SARS-CoV-2 from SARS-CoV-2 convalescents.

5 Apr 2022

Study investigates the local-mucosal susceptibility and innate immune response to Omicron compared to other variants

A recent study observed that the replication of the SARS-CoV-2 Omicron variant was restricted in human lung tissues

5 Apr 2022

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

Researchers assessed the cross-neutralization among three sublineages of the SARS-CoV-2 Omicron variant: BA.1, BA.2, and BA.3 sublineages, and an additional strain, USA/WA1-2020 (wild-type) in mice.

5 Apr 2022

Study generates a picture of the myocardial transcriptional landscape of COVID-19

Researchers profiled cardiac tissue transcriptomes of COVID-19 patients.

5 Apr 2022

Study on the efficacy of a BNT162b2 booster dose in the elderly

In a recent study posted to the medRxiv* preprint server, researchers characterized the immune responses against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron variant after receiving a booster dose of BNT162b2 vaccine in older people.

5 Apr 2022

Pandemic to endemic: downside risks of widespread SARS-CoV-2 transmission

In a recent study posted to the medRxiv* preprint server, researchers evaluated the impact of changes in infection fatality rate (IFR), intrinsic reproductive number (R0), and the durability of immunity on the annual coronavirus disease 2019 (COVID-19) death toll in the United States (US). This study demonstrated the risks of abiding by the ‘live with the disease’ COVID-19 mitigation strategy.

4 Apr 2022

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

The SAVE initiative assesses the impact of SARS-CoV-2 variants on diagnostics, vaccines, and therapies, as well as communicating public health dangers.

4 Apr 2022

immunity News and Research

Israeli research confirms BNT162b2 booster's effectiveness

How effective are mRNA boosters against to Delta and Omicron?

Researchers discover over 40 new genetic markers for Alzheimer’s disease

New platform for studying how the immune system responds to hepatitis C

Cryo-EM imaging of a key immune protein reveals previously unrecognized binding site

Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

SARS-CoV-2 transmission from human to free-roaming dogs during a severe COVID-19 outbreak in the Amazonian Region of Ecuador

Self-assembling SARS-CoV-2 spike protein-directed nanoparticle vaccines

Study highlights immune escape mutations in viral N-terminal domain supersite of SARS-CoV-2 spike variants

How comorbidities impact antibody response to COVID vaccination

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

SARS-CoV-2 Omicron breakthrough infections induce antibodies with cross-variant neutralization potential and recall memory B cells

Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

Investigating extensive SARS-CoV-2 neutralizing immunoglobulins from COVID-19 recovered subjects

Study investigates the local-mucosal susceptibility and innate immune response to Omicron compared to other variants

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

Study generates a picture of the myocardial transcriptional landscape of COVID-19

Study on the efficacy of a BNT162b2 booster dose in the elderly

Pandemic to endemic: downside risks of widespread SARS-CoV-2 transmission

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News